Literature DB >> 22969848

Pathological observations of lung inflammation after administration of IP-10 in influenza virus- and respiratory syncytial virus-infected mice.

Hong Luo1, Dong Wang, Hai-Long Che, Yue Zhao, Hong Jin.   

Abstract

Pneumonia is a common complication of influenza virus infection and a common cause of death of patients. The aim of this study was to test the hypothesis that interferon-γ-inducible protein-10 (IP-10) is an important chemokine in the development of airway inflammation caused by certain viruses. Mice were infected with influenza virus after administration of murine IP-10 and the severity of pneumonia was compared with the group which was infected with influenza virus alone. Another mice group was infected with respiratory syncytial virus (RSV) after injection of IP-10 and also the severity of pneumonia was compared to the group which was infected with RSV alone. The mice infected with influenza virus or RSV after administration of IP-10 presented with more fulminant and necrotizing diffuse alveolar and bronchiole damage with lymphocyte infiltration. Our results indicate that IP-10 is an important chemokine and is associated with the severity of pneumonia caused by certain viruses.

Entities:  

Year:  2011        PMID: 22969848      PMCID: PMC3438799          DOI: 10.3892/etm.2011.350

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  12 in total

1.  Interferon-inducible protein 10, but not monokine induced by gamma interferon, promotes protective type 1 immunity in murine Klebsiella pneumoniae pneumonia.

Authors:  Xianying Zeng; Thomas A Moore; Michael W Newstead; Jane C Deng; Steven L Kunkel; Andrew D Luster; Theodore J Standiford
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus.

Authors:  T C Dawson; M A Beck; W A Kuziel; F Henderson; N Maeda
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

3.  IP-10 mediates selective mononuclear cell accumulation and activation in response to intrapulmonary transgenic expression and during adenovirus-induced pulmonary inflammation.

Authors:  Xianying Zeng; Thomas A Moore; Michael W Newstead; Jane C Deng; Nicholas W Lukacs; Theodore J Standiford
Journal:  J Interferon Cytokine Res       Date:  2005-02       Impact factor: 2.607

4.  Strain variation in BCG-induced chronic pulmonary inflammation in mice. I. Basic model and possible genetic control by non-H-2 genes.

Authors:  E M Allen; V L Moore; J O Stevens
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

5.  Acute inflammatory response and remodeling of airway epithelium after subspecies B1 human adenovirus infection of the mouse lower respiratory tract.

Authors:  Adriana E Kajon; Andrew P Gigliotti; Kevin S Harrod
Journal:  J Med Virol       Date:  2003-10       Impact factor: 2.327

6.  Induction of IP-10 (CXCL10) in astrocytes following Japanese encephalitis.

Authors:  Sourojit Bhowmick; Rachna Duseja; Sulagna Das; Mohan Babu Appaiahgiri; Sudhanshu Vrati; Anirban Basu
Journal:  Neurosci Lett       Date:  2007-01-08       Impact factor: 3.046

Review 7.  The pathology of influenza virus infections.

Authors:  Jeffery K Taubenberger; David M Morens
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

8.  Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells.

Authors:  M C W Chan; C Y Cheung; W H Chui; S W Tsao; J M Nicholls; Y O Chan; R W Y Chan; H T Long; L L M Poon; Y Guan; J S M Peiris
Journal:  Respir Res       Date:  2005-11-11

9.  Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome.

Authors:  Jung-Yien Chien; Po-Ren Hsueh; Wern-Cherng Cheng; Chong-Jen Yu; Pan-Chyr Yang
Journal:  Respirology       Date:  2006-11       Impact factor: 6.424

10.  Re-emergence of fatal human influenza A subtype H5N1 disease.

Authors:  J S M Peiris; W C Yu; C W Leung; C Y Cheung; W F Ng; J M Nicholls; T K Ng; K H Chan; S T Lai; W L Lim; K Y Yuen; Y Guan
Journal:  Lancet       Date:  2004-02-21       Impact factor: 79.321

View more
  8 in total

1.  The effect of dietary bovine colostrum on respiratory syncytial virus infection and immune responses following the infection in the mouse.

Authors:  Mei Ling Xu; Hyoung Jin Kim; Ga Ram Wi; Hong-Jin Kim
Journal:  J Microbiol       Date:  2015-08-27       Impact factor: 3.422

Review 2.  Influenza, immune system, and pregnancy.

Authors:  Renju S Raj; Elizabeth A Bonney; Mark Phillippe
Journal:  Reprod Sci       Date:  2014-06-04       Impact factor: 3.060

3.  Low-dose cadmium potentiates lung inflammatory response to 2009 pandemic H1N1 influenza virus in mice.

Authors:  Joshua D Chandler; Xin Hu; Eun-Ju Ko; Soojin Park; Jolyn Fernandes; Young-Tae Lee; Michael L Orr; Li Hao; M Ryan Smith; David C Neujahr; Karan Uppal; Sang-Moo Kang; Dean P Jones; Young-Mi Go
Journal:  Environ Int       Date:  2019-04-15       Impact factor: 9.621

4.  Substituted N-(4-amino-2-chlorophenyl)-5-chloro-2-hydroxybenzamide analogues potently inhibit respiratory syncytial virus (RSV) replication and RSV infection-associated inflammatory responses.

Authors:  Jimin Xu; Wenzhe Wu; Haiying Chen; Yu Xue; Xiaoyong Bao; Jia Zhou
Journal:  Bioorg Med Chem       Date:  2021-04-18       Impact factor: 3.461

5.  Glycemic Variability in Diabetes Increases the Severity of Influenza.

Authors:  Rebecca J Marshall; Pornthida Armart; Katina D Hulme; Keng Yih Chew; Alexandra C Brown; Philip M Hansbro; Conor J Bloxham; Melanie Flint; Katharina Ronacher; Helle Bielefeldt-Ohmann; Linda A Gallo; Kirsty R Short
Journal:  mBio       Date:  2020-03-24       Impact factor: 7.867

6.  Characterization of the In Vitro and In Vivo Efficacy of Baloxavir Marboxil against H5 Highly Pathogenic Avian Influenza Virus Infection.

Authors:  Keiichi Taniguchi; Yoshinori Ando; Masanori Kobayashi; Shinsuke Toba; Haruaki Nobori; Takao Sanaki; Takeshi Noshi; Makoto Kawai; Ryu Yoshida; Akihiko Sato; Takao Shishido; Akira Naito; Keita Matsuno; Masatoshi Okamatsu; Yoshihiro Sakoda; Hiroshi Kida
Journal:  Viruses       Date:  2022-01-08       Impact factor: 5.048

7.  Adenosine-to-inosine editing of endogenous Z-form RNA by the deaminase ADAR1 prevents spontaneous MAVS-dependent type I interferon responses.

Authors:  Qiannan Tang; Rachel E Rigby; George R Young; Astrid Korning Hvidt; Tanja Davis; Tiong Kit Tan; Anne Bridgeman; Alain R Townsend; George Kassiotis; Jan Rehwinkel
Journal:  Immunity       Date:  2021-09-14       Impact factor: 31.745

8.  Inflammation induced by influenza virus impairs human innate immune control of pneumococcus.

Authors:  Simon P Jochems; Fernando Marcon; Beatriz F Carniel; Mark Holloway; Elena Mitsi; Emma Smith; Jenna F Gritzfeld; Carla Solórzano; Jesús Reiné; Sherin Pojar; Elissavet Nikolaou; Esther L German; Angie Hyder-Wright; Helen Hill; Caz Hales; Wouter A A de Steenhuijsen Piters; Debby Bogaert; Hugh Adler; Seher Zaidi; Victoria Connor; Stephen B Gordon; Jamie Rylance; Helder I Nakaya; Daniela M Ferreira
Journal:  Nat Immunol       Date:  2018-10-29       Impact factor: 25.606

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.